Here, we aim to explore whether overexpression of Per2, a tumor suppressor gene, may inhibit the malignant phenotype of glioma based on regulating PTEN/AKT/Smad5/Id3 signaling pathway and would help to identify a novel target for clinical precision medicine. This evidence concerns the gene SMAD5 and glioma.